Psychopharmacology &

Psychedelic-Assisted Psychotherapy

A Paradigm Shift

in Psychiatric & Mental Health Services

The psychedelic drug MDMA will soon be FDA-approved for psychedelic-assisted therapy for people that suffer from mental health issues, such as depression and PTSD when other traditional treatments are unsuccessful. The drug ketamine has already been approved and is currently used by providers.

Touchstone Associates is excited to announce that by 2024 we will be working with mental health practitioners and patients to provide these groundbreaking treatments in our office.

“Several of the scientists I profile are convinced psychedelics could revolutionize mental healthcare and our understanding of the mind.”

— Michael Pollan, Author of the Book How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence